Curis, Inc. (CRIS)
1.20
+0.12
(+11.11%)
USD |
NASDAQ |
Feb 13, 11:15
Curis Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agenus, Inc. | 0.076M |
| LadRx Corp. | 0.00 |
| Windtree Therapeutics, Inc. | -0.789M |
| Enzon Pharmaceuticals, Inc. | 0.00 |
| Halozyme Therapeutics, Inc. | 201.61M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.569M |
| Cash from Financing (Quarterly) | 4.482M |
| Free Cash Flow | -30.09M |
| Free Cash Flow Per Share (Quarterly) | -0.3552 |
| Free Cash Flow to Equity (Quarterly) | -3.702M |
| Free Cash Flow to Firm (Quarterly) | -4.684M |
| Free Cash Flow Yield | -225.5% |